Tobacco Use Insights is a leading open-access journal dedicated to advancing the understanding of tobacco use and its implications for public health. Published by SAGE Publications Ltd, this journal provides a platform for innovative research, critical reviews, and practice-oriented articles that span the diverse dimensions of tobacco consumption, cessation, policy impacts, and prevention strategies. With a commitment to facilitating knowledge dissemination since its inception in 2009, Tobacco Use Insights serves an international audience of researchers, health professionals, and students who are engaged in the ongoing fight against tobacco-related health issues. The journal is indexed and accessible across multiple databases, reinforcing its influence within the field and ensuring wide visibility for its contributors. The journal's insightful contributions play an essential role in shaping effective tobacco control policies and fostering healthier communities globally.

Translational Behavioral Medicine, published by Oxford University Press, is a premier academic journal dedicated to advancing the field of behavioral medicine through high-quality research and innovative methodologies. With an ISSN of 1869-6716 and an impressive E-ISSN of 1613-9860, the journal serves as a vital platform for disseminating findings that bridge the gap between laboratory research and clinical practice. Ranking in the prestigious Q1 category for both Applied Psychology and Behavioral Neuroscience, it holds a prominent position within the academic community, as reflected by its Scopus rankings—17th out of 88 in Behavioral Neuroscience and 57th out of 249 in Applied Psychology. Although currently non-Open Access, the journal provides a wealth of knowledge for researchers, professionals, and students interested in the interplay of behavioral science and health. With converged years from 2011 to 2024, Translational Behavioral Medicine continues to be an essential resource for those committed to enhancing our understanding of how behavioral factors contribute to health and illness.

Infectious Diseases of Poverty, published by BMC, is a leading open-access journal dedicated to addressing the critical intersection of infectious diseases and poverty. Since its inception in 2012, this influential journal has contributed significantly to the fields of public health, infectious diseases, and environmental health. With impressive rankings placing it in the top quartile (Q1) across multiple categories—including Infectious Diseases and Public Health, Environmental and Occupational Health—it stands as a vital resource for researchers and practitioners alike. The journal's commitment to accessibility ensures that high-quality research is available to a global audience, fostering collaboration and knowledge sharing. Based in the UK, Infectious Diseases of Poverty aims to publish innovative research that sheds light on the complexities of infectious diseases and their socio-economic determinants, ultimately working to improve health outcomes in vulnerable populations around the world. With its robust impact factor and esteemed standing within the academic community, this journal serves as an essential platform for advancing the understanding and management of infectious diseases related to poverty.

JOURNAL OF PUBLIC HEALTH MANAGEMENT AND PRACTICE, published by Lippincott Williams & Wilkins, stands as a pivotal resource in the fields of Health Policy and Public Health. With an ISSN of 1078-4659 and an E-ISSN of 1550-5022, this journal has been disseminating high-quality research since its inception in 1995, serving a global audience from its base in the United States. Renowned for its contributions, it holds a respectable ranking within the Scopus database, positioned in the 55th percentile for both Public Health, Environmental and Occupational Health, and Health Policy. The journal’s focus is to provide a platform for scholarly articles that enhance the practice of public health management, making it an essential read for researchers, practitioners, and students alike. By fostering a community of informed professionals, the journal aims to bridge the gap between theory and practice, ensuring that advancements in public health are effectively addressed and disseminated.

China CDC Weekly is an esteemed academic journal published by the Chinese Center for Disease Control and Prevention, dedicated to disseminating critical research in the fields of epidemiology, infectious diseases, and public health. Since its inception in 2019, the journal has rapidly established itself as a key resource for scholars, professionals, and students, achieving notable rankings, including Q2 in Epidemiology and Infectious Diseases, and Q1 in Public Health, Environmental, and Occupational Health for 2023. With an emphasis on the latest advancements and data-driven insights, China CDC Weekly offers a platform for researchers to contribute to the vital discourse surrounding health policies, disease control, and public safety in a rapidly evolving global landscape. As an open-access journal, it ensures widespread availability and visibility of research findings, reflecting its commitment to advancing public health knowledge in China and beyond. The conference years from 2019 to 2024 further highlight its responsiveness to emerging health challenges and trends, positioning the journal as a preeminent publication for interdisciplinary collaboration and innovation.

Allergy Asthma & Respiratory Disease is a pioneering journal dedicated to advancing research and clinical practice in the fields of allergy, asthma, and related respiratory diseases. Published by the esteemed Korean Academy of Asthma Allergy & Clinical Immunology, this journal aims to disseminate high-quality, peer-reviewed articles that contribute to the understanding, diagnosis, and treatment of these prevalent health issues. Although it operates under a subscription model, it maintains a robust reputation for being a pivotal resource in respiratory health, attracting authors and researchers worldwide. The journal emphasizes interdisciplinary approaches and encourages submissions that span from molecular biology to public health perspectives, making it a vital platform for professionals, researchers, and students eager to deepen their knowledge in respiratory medicine. With a commitment to fostering academic discourse in South Korea and beyond, Allergy Asthma & Respiratory Disease is positioned as a significant contributor to the global conversation on respiratory health.

PLoS Neglected Tropical Diseases is a leading Open Access journal published by the Public Library of Science since 2007, dedicated to advancing research and awareness in the field of neglected tropical diseases. With an impressive 2023 impact factor reflected in its Q1 ranking in categories such as Infectious Diseases, Pharmacology, Toxicology and Pharmaceutics, as well as Public Health, Environmental and Occupational Health, this journal is recognized as a vital resource for researchers, healthcare professionals, and students alike. It is positioned prominently within the academic community, ranked in the top tier of journals according to Scopus, demonstrating its significant contribution to knowledge and innovation in global health. With its commitment to disseminating free and accessible scientific insights, PLoS Neglected Tropical Diseases plays a crucial role in addressing pressing health challenges and promoting a deeper understanding of diseases often overlooked in mainstream health discourse. For further information and to access its rich repository of articles, please visit the journal's website.

Addicta - The Turkish Journal on Addictions, published by the esteemed Turkish Green Crescent Society, is an open access journal dedicated to advancing the understanding of addictions and their implications on mental health. Since its inception in 2019, this journal has become a significant platform for interdisciplinary research, focusing on the biological, psychological, and sociocultural aspects of addiction. With a focus on both empirical studies and theoretical discussions, Addicta seeks to foster a greater understanding of addiction as a complex phenomenon, facilitating knowledge sharing among researchers, practitioners, and policymakers. The journal has achieved notable rankings, residing in the Q4 category in Biological Psychiatry and Psychiatry and Mental Health, and Q3 in miscellaneous Psychology, marking its growing impact in the field. Accessing its content is completely free, making important research accessible to a broader audience. Based in Turkey, Addicta provides a vital resource for those interested in the nuances of addiction research, promoting innovative solutions and fostering collaboration across disciplines.

Tobacco Induced Diseases is a leading open-access journal published by EUROPEAN PUBLISHING, dedicated to advancing research in the critical fields of tobacco-related health issues, epidemiology, and public policy. With an ISSN of 1617-9625, this esteemed journal has been nurturing academic discourse since its inception in 2002, situated in the picturesque backdrop of Heraklion, Crete. Recognized for its rigorous publication standards and impactful contributions, the journal proudly holds a Q1 ranking in Health (Social Science) and consistently ranks within the top quarters for both Medicine (Miscellaneous) and Public Health, Environmental, and Occupational Health. With impressive Scopus rankings, including #67 in Health and #99 in Medicine, it serves as an essential platform for researchers, professionals, and students aiming to understand and address the pressing challenges associated with tobacco use and its long-term health implications. As the journal converges its research coverage from 2009 to 2024, it invites contributions that span multidisciplinary perspectives and innovative approaches to tackling tobacco-induced diseases.

Journal of Inflammation-London, published by BMC, is a premier open access journal dedicated to advancing the understanding of inflammation, a critical process underlying numerous diseases including autoimmune disorders, cancer, and cardiovascular conditions. With its inception in 2004, the journal has consistently delivered high-quality research that bridges basic science and clinical applications, maintaining a significant place in the academic community. It holds impressive rankings within the Q2 category for both Cell Biology and Clinical Biochemistry, reflecting its impactful contributions to these fields, where it ranks in the 73rd and 64th percentiles respectively. The journal is committed to open access principles, ensuring that all published articles are freely available to researchers, practitioners, and the global community, thereby fostering collaboration and innovation. Located in the United Kingdom, the journal continues to attract submissions from prominent researchers and institutions worldwide, solidifying its status as an essential resource for the latest developments in inflammation research.